These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38749514)
1. Paradoxical masseteric bulging after botulinum neurotoxin type A injection. Sandhu S; Shaefer J BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38749514 [TBL] [Abstract][Full Text] [Related]
2. Ultrasonographic Considerations for Safe and Efficient Botulinum Neurotoxin Injection in Masseteric Hypertrophy. Lee HJ; Jung SJ; Kim ST; Kim HJ Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33406757 [TBL] [Abstract][Full Text] [Related]
3. The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection. Lee HJ; Kang IW; Seo KK; Choi YJ; Kim ST; Hu KS; Kim HJ Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28042813 [TBL] [Abstract][Full Text] [Related]
4. Comparison between Conventional Blind Injections and Ultrasound-Guided Injections of Botulinum Toxin Type A into the Masseter: A Clinical Trial. Bae H; Kim J; Seo KK; Hu KS; Kim ST; Kim HJ Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932891 [TBL] [Abstract][Full Text] [Related]
5. Anatomical Considerations When Treating Compensatory Hypertrophy of the Upper Part of the Masseter after Long-Term Botulinum Neurotoxin Type A Injections. Lee KL; Cho HJ; Bae H; Park HJ; Park MS; Kim HJ Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32235784 [TBL] [Abstract][Full Text] [Related]
6. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy. Ahn KY; Kim ST Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203 [TBL] [Abstract][Full Text] [Related]
7. Does Botulinum Toxin Injection into Masseter Muscles Affect Subcutaneous Thickness? Park G; Choi YC; Bae JH; Kim ST Aesthet Surg J; 2018 Feb; 38(2):192-198. PubMed ID: 29117291 [TBL] [Abstract][Full Text] [Related]
8. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement. Kim HJ; Yum KW; Lee SS; Heo MS; Seo K Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515 [TBL] [Abstract][Full Text] [Related]
9. Do repetitive botulinum neurotoxin injections induce muscle fibrosis? Sonographic observation of the masseter muscle. Koo HJ; Hu H; Kim W; Kim JS; Kim HJ; Yi KH J Cosmet Dermatol; 2024 Feb; 23(2):434-440. PubMed ID: 37942679 [TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin type A on contouring of the lower face. Choe SW; Cho WI; Lee CK; Seo SJ Dermatol Surg; 2005 May; 31(5):502-7; discussion 507-8. PubMed ID: 15962731 [TBL] [Abstract][Full Text] [Related]
11. Acute visual loss after botulinum toxin A injection in the masseter muscle. Chun BY; Kim SY Int Ophthalmol; 2018 Jun; 38(3):1339-1342. PubMed ID: 28536763 [TBL] [Abstract][Full Text] [Related]
12. Paradoxical bulging of mentalis after botulinum toxin type A injection. Yu N; Liu Y; Chen C; Dong R; Yang E; Wang X J Cosmet Dermatol; 2020 Jun; 19(6):1290-1293. PubMed ID: 32346978 [TBL] [Abstract][Full Text] [Related]
13. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients. Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570 [TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy. Arikan OK; Tan FU; Kendi T; Koc C J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016 [TBL] [Abstract][Full Text] [Related]
15. An Ultrasonographic Analysis of the Deep Inferior Tendon in the Masseter Muscle: Implications for Botulinum Toxin Injections. Shi J; Li C; Zhou J; Guo X; Li G; You M Toxins (Basel); 2024 Sep; 16(9):. PubMed ID: 39330849 [TBL] [Abstract][Full Text] [Related]
16. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter. Kaya B; Apaydin N; Loukas M; Tubbs RS J Plast Reconstr Aesthet Surg; 2014 Dec; 67(12):1663-8. PubMed ID: 25175271 [TBL] [Abstract][Full Text] [Related]
17. The use of botulinum toxin type A in aesthetic mandibular contouring. Kim NH; Chung JH; Park RH; Park JB Plast Reconstr Surg; 2005 Mar; 115(3):919-30. PubMed ID: 15731696 [TBL] [Abstract][Full Text] [Related]
18. Botulinum Toxin Injections for Masseter Reduction in East Asians. Cheng J; Hsu SH; McGee JS Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A treatment for contouring of the lower face. Park MY; Ahn KY; Jung DS Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A. Lee JH; Park JH; Lee SK; Han KH; Kim SD; Yoon CS; Park JY; Lee JH; Yang JM; Lee JH J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]